Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 46

Results For "clinical"

3755 News Found

Philips unveils AI-powered SmartIQ to enhance coronary imaging
Medical Device | May 20, 2026

Philips unveils AI-powered SmartIQ to enhance coronary imaging

New CE-marked algorithm for the Azurion platform delivers improved image quality with over 50% lower radiation dose compared to the lowest settings on ClarityIQ


HVS Hospitals records highest advanced clip therapy procedures in western India
Hospitals | May 20, 2026

HVS Hospitals records highest advanced clip therapy procedures in western India

The therapy is suited for patients with severe valve leakage who face elevated surgical risk due to advanced age, frailty, or multiple medical complications


360 ONE-backed Hearzap to acquire Amplifon India
Healthcare | May 20, 2026

360 ONE-backed Hearzap to acquire Amplifon India

Combined footprint expands to 420 hearing care centres across India


MedGenome to expand integrated diagnostics access across Mumbai suburbs
Healthcare | May 19, 2026

MedGenome to expand integrated diagnostics access across Mumbai suburbs

Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets


Strand Life launches advanced proteomics capabilities
Biopharma | May 19, 2026

Strand Life launches advanced proteomics capabilities

The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample


SN Bioscience doses first patient in global trial of experimental drug for aggressive lung cancer
Clinical Trials | May 19, 2026

SN Bioscience doses first patient in global trial of experimental drug for aggressive lung cancer

The drug also delivered a disease control rate (DCR) of 83.3% in high-dose cohorts and a mean progression-free survival of 6.3 months in SCLC patients


Bayer’s NUBEQA combo shows 71% drop in risk of progression or death in prostate cancer trial
Clinical Trials | May 19, 2026

Bayer’s NUBEQA combo shows 71% drop in risk of progression or death in prostate cancer trial

Despite the strong results, investigators cautioned that the study has limitations, including its open-label Phase II design, lack of randomization, and reliance on a historical external control arm


FDA expands Enhertu use in early HER2-positive breast cancer
Drug Approval | May 19, 2026

FDA expands Enhertu use in early HER2-positive breast cancer

AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease


OrganaBio expands cell therapy manufacturing footprint with acquisition of Excellos Assets
Biotech | May 19, 2026

OrganaBio expands cell therapy manufacturing footprint with acquisition of Excellos Assets

The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego